Docusate Sodium
- Product NDC
- 0121-0935
- 11-digit product format
- 001210935
- Labeler code
- 0121
- Product ID
- 0121-0935_5cfc4685-c885-4303-a988-5009cbd8e57b
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Docusate Sodium
- Dosage form
- LIQUID
- Route
- ORAL
- Labeler
- PAI Holdings, LLC dba PAI Pharma
- Application
- M007
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2021-08-16
- Substance
- DOCUSATE SODIUM
- Active strength
- 50 mg/5mL
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 0121-0935 | 0121-0935-16 | D | Discontinued by firm | 2026-11-19 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 0121-0935 | 0121-0935-16 | D | Discontinued by firm | excluded / ndc_excluded.zip | d630ba8d3edf… | 732f749b63fb… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Docusate Sodium
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| DOCUSATE SODIUM | 50 mg/5mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| F05Q2T2JA0 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1245686 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| e975a3f1-0e1f-4fb8-9c5f-baa75e12f2a5 | Available on FDA.report |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0121-0935-05 | Docusate Sodium | 5 mL in 1 CUP, UNIT-DOSE | LIQUID | 5 | 9 | |
| 0121-0935-16 | Docusate Sodium | 473 mL in 1 BOTTLE | LIQUID | 473 | 9 | |
| 0121-0935-40 | Docusate Sodium | 10 in 1 TRAY | LIQUID | 10 | 9 | |
| 0121-0935-40 | Docusate Sodium | 4 in 1 CASE | LIQUID | 4 | 9 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0121-0935-05 | ML - Milliliter | 0121-0935 | bd4be1fb-4d63-4e7c-8bfa-2e34cd4de1c5 | 1 | 2021-10-08 |
| 0121-0935-16 | ML - Milliliter | 0121-0935 | 3bdd2684-e7df-4efc-abb2-b74bbcf7d516 | 1 | 2021-10-08 |
| 0121-0935-40 | ML - Milliliter | 0121-0935 | 3327600b-3340-46f6-b2a4-f6be1a4545bb | 1 | 2021-10-08 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| STOOL SOFTENER | DOCUSATE SODIUM | Walgreen Co. | d8d97ca5-5131-4620-8ce9-bc3f9d5c0ab5 | 2024-11-21 | Warnings | M007 |
| 4718 Enema, Mineral Oil | 4718 ENEMA, MINERAL OIL | Dynarex | 9e51c852-9477-5cf5-e053-2a95a90a97db | 2024-11-20 | Warnings | M007 |
| Relief | SODIUM PHOSPHATE, MONOBASIC AND SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | Leosons Overseas Corp | 5b301d5b-1e2c-47ed-a05f-d6be0fdfc940 | 2024-11-19 | Warnings | M007 |
| REFLIEF SALINE LAXATIVE PEDIATRIC READY TO USE | SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM AND SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM | Leosons Overseas Corp | 90e7c2b4-35e1-4a27-afea-9257c480e190 | 2024-11-19 | Warnings | M007 |
| Stool Softener | DOCUSATE SODIUM 100MG | PuraCap Pharmaceutical LLC | 272c86f1-f229-2ebf-e063-6394a90a3471 | 2024-11-18 | Warnings | M007 |
| Milk of Magnesia Concentrate | MAGNESIUM HYDROXIDE | PAI Holdings, LLC dba PAI Pharma | 2a99a1a8-a830-429f-9cfd-3f29c3d3547c | 2024-11-12 | Warnings | M007 |
| Docusate Sodium | DOCUSATE SODIUM | A-S Medication Solutions | 122486e9-74dd-4181-97d1-0b07688280f4 | 2024-11-06 | Warnings | M007 |
| Stratuscare Adult Glycerin | GLYCERIN | Stratus Pharmaceuticals | 3e1935da-5c1f-4942-98dd-320fade82321 | 2024-11-04 | Warnings | M007 |
| DOCUSATE SODIUM | DOCUSATE SODIUM | NuCare Pharmaceuticals,Inc. | fdf3c8e1-d554-4cdb-e053-6394a90a542e | 2024-11-01 | Warnings | M007 |
| Stratuscare Glycerin Laxative Pediatric | GLYCERIN | Stratus Pharmaceuticals | 6ae6d3c4-bb3b-4436-b76d-8654bf871e66 | 2024-11-01 | Warnings | M007 |
| Rite Aid Fiber Therapy | METHYLCELLULOSE | RITE AID CORPORATION | e50cea80-c020-4b85-b61f-d053f11f479b | 2024-10-30 | Warnings | M007 |
| Rite Aid Fiber Caplets | CALCIUM POLYCARBOPHIL | RITE AID CORPORATION | 06e46cb0-2928-479e-984d-2305fff995e0 | 2024-10-30 | Warnings | M007 |
| Premier Value Orange Flavor | PSYLLIUM HUSK | PHARMACY VALUE ALLIANCE, LLC | 2d580965-2bef-46ee-8532-fbe34330a4b4 | 2024-10-28 | Warnings | M007 |
| Premier Value Fiber Therapy | METHYLCELLULOSE | PHARMACY VALUE ALLIANCE, LLC | b875d5f8-02f3-4474-9fda-83091bc7de04 | 2024-10-28 | Warnings | M007 |
| Premier Value Fiber Therapy Original Coarse | PSYLLIUM HUSK | PHARMACY VALUE ALLIANCE, LLC | 8c85a13d-ae99-4599-9a28-c3965caa6376 | 2024-10-28 | Warnings | M007 |
| Premier Value | CALCIUM POLYCARBOPHIL | PHARMACY VALUE ALLIANCE, LLC | 4d766548-00d0-41bd-bb58-b69e037c77e2 | 2024-10-28 | Warnings | M007 |
| Premier Value Fiber | PSYLLIUM HUSK | Chain Drug Consortium, LLC | c507fe4a-1f8e-4780-a2f5-9da6e5922bef | 2024-10-28 | Warnings | M007 |
| Premier Value Fiber Therapy Orange Flavor | PSYLLIUM HUSK | PHARMACY VALUE ALLIANCE, LLC | 85651bd7-e959-4455-a5ed-bd0223ce0563 | 2024-10-28 | Warnings | M007 |
| Stool Softener | DOCUSATE SODIUM AND SENNOSIDES | BETTER LIVING BRANDS LLC. | f2c61c71-9a23-4bd3-e053-2a95a90ad460 | 2024-10-26 | Warnings | M007 |
| Pedia-Lax | GLYCERIN | C.B. Fleet Company, Inc. | ae367381-7146-4307-823d-2bb44c1d4200 | 2024-10-25 | Warnings | M007 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1245686 | docusate sodium 50 MG in 5 mL Oral Solution | PSN | e975a3f1-0e1f-4fb8-9c5f-baa75e12f2a5 | 9 |
| 1245686 | docusate sodium 10 MG/ML Oral Solution | SCD | e975a3f1-0e1f-4fb8-9c5f-baa75e12f2a5 | 9 |
| 1245686 | docusate sodium 10 MG per 1 ML Oral Solution | SY | e975a3f1-0e1f-4fb8-9c5f-baa75e12f2a5 | 9 |
| 1245686 | docusate sodium 100 MG per 10 ML Oral Solution | SY | e975a3f1-0e1f-4fb8-9c5f-baa75e12f2a5 | 9 |
| 1245686 | docusate sodium 150 MG per 15 ML Oral Solution | SY | e975a3f1-0e1f-4fb8-9c5f-baa75e12f2a5 | 9 |
| 1245686 | DOSS Sodium 10 MG/ML Oral Solution | SY | e975a3f1-0e1f-4fb8-9c5f-baa75e12f2a5 | 9 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 0121-0935-05 | 00121093505 | 5 mL in 1 CUP, UNIT-DOSE | 5 ml | Historical | ||||
| 0121-0935-16 | 00121093516 | 473 mL in 1 BOTTLE (0121-0935-16) | 473 ml | 2021-08-16 | 0000-00-00 | No | No | Current |
| 0121-0935-40 | 00121093540 | 4 TRAY in 1 CASE (0121-0935-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (0121-0935-05) | 4 tray | 2021-08-16 | 0000-00-00 | No | No | Current |